Wellcome Trust
FoundationLondon · Seed–Late Stage
Founder mafia
2 people who came through Wellcome Trust went on to found or lead other companies.
What they invest in
from 9 of 9 portfolio companiesBiotech ×4Healthtech ×4Deep Tech ×3Medical Devices ×3Energy ×2AI & Machine Learning ×1Cleantech ×1Consumer ×1
HQs:United States×5France×1United Kingdom×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2026 · 12017 · 12016 · 12015 · 14 dated
CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions.
Deep TechHealthtechMedical DevicesHouston, US
John Criscione(Director)inWilliam Altman(Executive Officer, Director)inDennis Robins(Director)Boris Leschinsky(Executive Officer)Clarice Motter(Executive Officer)Keith Svagerko(Executive Officer)
Co-investorsHouston Angel NetworkKeiretsu ForumTMC Venture FundCowtown AngelsHarvard Business School Alumni Angels of Greater New YorkAggie Angel Network+1 more
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWren CapitalCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more
Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform.
BiotechHealthtechMedical DevicesLyon, FR
Alexandre Le Vert(Executive Chairman & Co-Founder)Dr Florence Nicolas(Chief Scientific Officer & Co-Founder)Dr Fergal Hill(Co-founder)
Co-investorsStart CapitalCAP HORN VC
TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.
CleantechDeep TechEnergyFoothill Ranch, US
Norman Rostoker(Co-founder)Michl Binderbauer(CEO)inCedric Burgher(Chief Financial Officer)in
Co-investorsNew Enterprise Associates (NEA)Chevron Technology VenturesCapital FactoryUpVentures CapitalVenrockRUSNANO
Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data.
AI & Machine LearningDeep TechLondon, GB
David Silver(Founder)inAlexandre Laterre(Co-Founder)inChris Apps(Founder)in
BoardAlfred Lin(Director (Sequoia Capital))Ravi Mhatre(Director (Lightspeed))
Co-investorsEQT VenturesFlying Fish VenturesIndex VenturesLightspeed Venture PartnersSequoia CapitalBond Capital Management+6 more
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante Health VenturesSante Ventures
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.
ConsumerMedia & Entertainment
Co-investorsAndera PartnersBrace PharmaNew Leaf Venture PartnersOrbiMed
EnergySan Diego, US
James E. Levine(Chief Executive Officer and President)James Astwood(Senior Vice President of Product Management)James Butler(Vice President of Legal Affairs and Intellectual Property)Thomas Willardson(Chief Financial Officer)
BoardSteven Goldby(Director)Eric Luo(Director)
Co-investorsARCH Venture PartnersVenrock
Portfolio news
latest coverage across their companies
Tri Alpha Energy · techcrunch.com · Aug 15, 2026
Ineffable Intelligence · ai-updates.net · Aug 9, 2026
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2016
Director · Australian · since 2021
Director · British · since 2019
Director · Chinese · since 2021
Director · British · since 2023
Director · British · since 2023
Director · United Kingdom · since 2018
Director · British · since 2019
Director · Senegalese · since 2020
Director · British · since 2021
Frequently asked questions
- What stage does Wellcome Trust invest at?
- Wellcome Trust invests at the Seed, Series B, Series C, Growth, Late Stage stages.
- What sectors does Wellcome Trust focus on?
- Wellcome Trust focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Wellcome Trust located?
- Wellcome Trust is headquartered in London, GB.
Similar investors
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
SBCVC (SoftBank China Venture Capital) is a venture capital and private equity fund management firm founded in 2000, focused on investing in high-growth, high-tech companies in Greater China.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.